$30 Billion Deal, page-4654

After looking through the Announcements all I can see is that they changed the wording from,
"preliminary results" expected, to
"headline results" expected in "coming weeks"

The last Half Year Report for the half year ended 31 December 2023 on 27 Feb said:
"• Continued post-clinical phase activities for all three Phase 2 trials including site monitoring and close-out, and finalising statistical analyses plans ahead of locking of trial databases and unblinding of data."

Which sounded like things were pretty close to the unblinding of data,
And Release of Results.

Although the Half Year report only was for up to 31 December,
As was the Quarterly.

So really we don't know what progress has made since then,
Which means basically we have got no new news since December 31st.

Anyhow only 5% of shareholders are required to request a meeting,
And put the question to them.

One could say well if they were doing monitoring and close-out, and finalising statistical analyses plans ahead of locking of trial databases and unblinding of data, by December,
Surely results must be much closer than they were then,
Hopefully any Day Now !!!!